{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:09:27Z","timestamp":1648739367433},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.medcli.2009.11.027","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T08:44:15Z","timestamp":1264581855000},"page":"445-447","source":"Crossref","is-referenced-by-count":1,"title":["Diagn\u00f3stico del s\u00edndrome antifosfolip\u00eddico: m\u00e1s actores, los mismos protagonistas"],"prefix":"10.1016","volume":"134","author":[{"given":"Guillermo","family":"Ruiz-Irastorza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2009.11.027_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2009.11.027_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0140-6736(93)91477-4","article-title":"The antiphospholipid syndrome: Ten years on","volume":"342","author":"Hughes","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2009.11.027_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2009.11.027_bib4","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","article-title":"A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus","volume":"42","author":"Hanly","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2009.11.027_bib5","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1001\/archinte.166.20.2278","article-title":"Cognitive deficits in patients with antiphospholipid syndrome: Association with clinical, laboratory, and brain magnetic resonance imaging findings","volume":"166","author":"Tektonidou","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2009.11.027_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1191\/0961203304lu2030oa","article-title":"Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus","volume":"13","author":"Ruiz-Irastorza","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2009.11.027_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncprheum0740","article-title":"Mechanisms of disease: Antiphospholipid antibodies-from clinical association to pathologic mechanism","volume":"4","author":"De Laat","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.medcli.2009.11.027_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: Pathogenic mechanisms","volume":"34","author":"Pierangeli","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.medcli.2009.11.027_bib9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nature Med"},{"key":"10.1016\/j.medcli.2009.11.027_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2009.11.027_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199707173370303","article-title":"Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism","volume":"337","author":"Rand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2009.11.027_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.medcli.2009.09.040","article-title":"Anti-annexin A5 antibodies in women with spontaneous pregnancy loss","volume":"134","author":"Alijotas-Reig","year":"2010","journal-title":"Med Clin"},{"key":"10.1016\/j.medcli.2009.11.027_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0029-7844(03)00363-6","article-title":"Antiphospholipid syndrome: Obstetric diagnosis, management and controversies","volume":"101","author":"Branch","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.medcli.2009.11.027_bib14","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2009.11.027_bib15","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2009.11.027_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2009.11.027_bib17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203307083316","article-title":"Transiently positive anticardiolipin antibodies do not increase the risk of thrombosis in patients with systemic lupus erythematosus","volume":"16","author":"Mart\u00ednez-Berriotxoa","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2009.11.027_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: A case-control study","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.medcli.2009.11.027_bib19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1538-7836.2005.01295.x","article-title":"A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis","volume":"3","author":"Forastiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2009.11.027_bib20","first-page":"2214","article-title":"Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: A metaanalysis","volume":"33","author":"Opatrny","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2009.11.027_bib21","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"De Laat","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2009.11.027_bib22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2006-07-030148","article-title":"Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5","volume":"109","author":"De Laat","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2009.11.027_bib23","article-title":"The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: An international multicenter study","volume":"19","author":"De Laat","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2009.11.027_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.medcli.2008.10.046","article-title":"El s\u00edndrome antifosfol\u00edpido en el siglo XXI","volume":"133","author":"Ruiz-Irastorza","year":"2009","journal-title":"Med Clin (Barc)"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775309016303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775309016303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T18:54:46Z","timestamp":1544727286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775309016303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0025775309016303"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2009.11.027","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}